For more information or confidential assistance
Call 800-306-3180

Researchers Say Diabetic Ketoacidosis is Preventable

diabetes
Federal health regulators have recently raised concerns about diabetic ketoacidosis, a possible side effect of Invokana and other SGLT2 inhibitors. Researchers suggest that ensuring doctors are very clearly informed of the risk may help identify most cases and avert severe harm. The medical journal Diabetes... Read More

AACE Plans Meeting to Examine SGLT2 Inhibitor Side Effects

diabetes
In late June, the American Association of Clinical Endocrinologists announced plans for a conference where U.S. and international experts will examine whether SGLT2 inhibitor side effects include diabetic ketoacidosis. Organizers hope the meeting will provide answers to questions from AACE members regarding recent reports and... Read More